Skip to main content
logo
Relay Therapeutics logo
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
17.36
-0.62 (-3.45%)
At close: Oct 13, 2026, 4:00 PM EDT
17.37
+0.01 (0.06%)
After-hours: Oct 13, 2026, 7:30 PM EDT

Relay Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-286.04-276.48-337.71-341.97-290.51-363.87
Depreciation & Amortization
2.213.565.465.274.133.93
Loss (Gain) From Sale of Assets
0.391----
Asset Writedown & Restructuring Costs
-2.3---123
Loss (Gain) From Sale of Investments
-3.36-4.95-12.42-10.761.1813.91
Stock-Based Compensation
48.3162.4294.1486.0356.1448.45
Other Operating Activities
---13.21-6.42-11.682.84
Change in Accounts Receivable
---5.22-0.2877.79
Change in Accounts Payable
17.15-11.4410.27-9.5911.290.93
Change in Unearned Revenue
--7.687.68--0.25-
Change in Other Net Operating Assets
9.14-4.19-3.33-28.090.4818.62
Operating Cash Flow
-212.21-235.46-249.11-300.32-229.49-74.41
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.41-2.02-4.13-9.06-3.47
Cash Acquisitions
------25.3
Investment in Securities
-244.94193.21-39.07261.76-179.68-450.74
Investing Cash Flow
-244.94192.8-41.08257.63-188.75-479.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
463.471.6270.1534.75289.91388.09
Financing Cash Flow
463.471.6270.1534.75289.91388.09

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
6.33-41.05-20.04-7.93-128.33-165.83

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-212.21-235.87-251.13-304.44-238.55-77.88
Free Cash Flow Growth
------
Free Cash Flow Margin
-2050.29%-1536.08%-2509.49%-1191.74%-17273.86%-2571.05%
Free Cash Flow Per Share
-1.17-1.38-1.76-2.48-2.13-0.82
Levered Free Cash Flow
-119.24-141.28-131.63-183.52-108.6-8.17
Unlevered Free Cash Flow
-119.24-141.28-131.63-183.52-108.6-8.17

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
26.29-23.3114.62-32.4611.2597.34
SEC Filings: 10-K · 10-Q